COSMO PHARMACEUTICALS N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.9 CHF | -0.82% |
|
+2.68% | +43.22% |
| Apr. 26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
| Apr. 25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Evolution of the average Target Price on Cosmo Pharmaceuticals N.V.
Price target over the last 5 years
History of analyst recommendation changes
faa849876b.yeQcoNAMyBrW8_dxA9q0U3vbDGU4K3FBzFX45YNePgE.jZJl9ad-uEyww51HO4z8ACnsRhd_ajg3vyGQosEfUTewu3HYm3ysS-Crug~8f627168dfa96201d6de25d56ea8155e
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
73.88
EUR
Average target price
94.95
EUR
Spread / Average Target
+28.53%
High Price Target
111
EUR
Spread / Highest target
+50.26%
Low Price Target
81.69
EUR
Spread / Lowest Target
+10.57%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cosmo Pharmaceuticals N.V.
| Berenberg Bank | |
| Research Capital |
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
- Stock Market
- Equities
- COPN Stock
- Consensus Cosmo Pharmaceuticals N.V.
